Steven J. Moss
Isomerase Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Microbial Natural Products and Biosynthesis, Signaling Pathways in Disease, Synthetic Organic Chemistry Methods, Chemical Synthesis and Analysis, Hepatitis C virus research
Most-Cited Works
- → The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin from Actinosynnema pretiosum(2002)284 cited
- → Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055(2004)151 cited
- → Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency(2016)149 cited
- → Loss of co-linearity by modular polyketide synthases: a mechanism for the evolution of chemical diversity(2004)137 cited
- → Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis(2005)107 cited
- → Biosynthesis of the immunosuppressants FK506, FK520, and rapamycin involves a previously undescribed family of enzymes acting on chorismate(2011)107 cited
- → Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects(2015)94 cited
- → Diversity oriented biosynthesis via accelerated evolution of modular gene clusters(2017)92 cited
- → Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors(2008)86 cited
- → Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo(2014)82 cited